- Home
- APGE vs DFH Comparison
APGE vs DFH Comparison
Compare APGE & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- DFH
- Stock Information
- Founded
- APGE 2022
- DFH 2008
- Country
- APGE United States
- DFH United States
- Employees
- APGE N/A
- DFH N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- DFH Homebuilding
- Sector
- APGE Health Care
- DFH Consumer Discretionary
- Exchange
- APGE Nasdaq
- DFH Nasdaq
- Market Cap
- APGE 2.3B
- DFH 2.0B
- IPO Year
- APGE 2023
- DFH 2021
- Fundamental
- Price
- APGE $34.55
- DFH $21.30
- Analyst Decision
- APGE Strong Buy
- DFH Hold
- Analyst Count
- APGE 5
- DFH 1
- Target Price
- APGE $83.50
- DFH $32.00
- AVG Volume (30 Days)
- APGE 514.4K
- DFH 378.0K
- Earning Date
- APGE 03-04-2025
- DFH 03-07-2025
- Dividend Yield
- APGE N/A
- DFH N/A
- EPS Growth
- APGE N/A
- DFH 15.80
- EPS
- APGE N/A
- DFH 3.03
- Revenue
- APGE N/A
- DFH $4,028,851,000.00
- Revenue This Year
- APGE N/A
- DFH $15.56
- Revenue Next Year
- APGE N/A
- DFH N/A
- P/E Ratio
- APGE N/A
- DFH $7.04
- Revenue Growth
- APGE N/A
- DFH 8.59
- 52 Week Low
- APGE $32.46
- DFH $20.54
- 52 Week High
- APGE $72.29
- DFH $44.38
- Technical
- Relative Strength Index (RSI)
- APGE 35.39
- DFH 38.94
- Support Level
- APGE $32.46
- DFH $21.28
- Resistance Level
- APGE $37.42
- DFH $23.00
- Average True Range (ATR)
- APGE 2.17
- DFH 0.96
- MACD
- APGE -0.30
- DFH 0.06
- Stochastic Oscillator
- APGE 20.84
- DFH 30.52
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. It designs, builds, and sells homes in Jacksonville, Orlando, Denver, the Washington D.C. metropolitan area, and Austin. The company operates through six geographical divisions namely, Jacksonville, Orlando, Denver, Washington DC (Capital), and the Carolinas (H&H Homes), Jet Home Loans LLC. Jacksonville division generates majority of the revenue for the firm.